Evaluating AI Medical Billing Services for Small Practices

Small practices lose money to bad billing every single month, and most of them cannot say exactly where it goes. That's the actual subject here: what to look for when evaluating an AI medical billing vendor, and why the criteria that matter for a 200-provider health system do not transfer cleanly to a four-physician group. Cloud-native platforms and more flexible pricing models have made automation increasingly reachable for independent practices and smaller healthcare organizations that never had the capital for enterprise RCM systems. The access gap is closing. The evaluation gap is not, and most small practices are about to make an expensive mistake trying to close it: they'll pick the vendor with the slickest AI pitch instead of the one that actually reports its numbers.

The vendors built specifically for small to mid-size practices, rather than enterprise RCM, include PracticeSuite, CureMD, DrChrono, CharmHealth, NextGen Healthcare, and DoctorConnect RCM, along with full-service managed billing operations such as Altair Health. Pricing structures across this segment range from flat per-provider monthly fees to a percentage of collections, with reputable billing companies typically charging mid-single digits to 10% of monthly collections. CharmHealth starts free and charges for added features, letting practices adopt incrementally; DrChrono runs $199 to $499 per provider monthly plus additional fees; others require direct inquiry. The foundational choice before comparing any of them is whether the practice needs software its own team will operate, or a managed service that pairs AI claim scrubbing with in-house billing specialists who work the exceptions the AI surfaces.

What is actually at stake: the revenue small practices are already losing

Denial rates are climbing, not stabilizing. Initial claim denials hit 11.8% in 2024, up from 10.2% just a few years prior, and Medicare Advantage denials alone jumped 4.8% between 2023 and 2024. More than 41% of providers surveyed recently reported denial rates above 10%, meaning a large share of small practices are running double the target ceiling of 5%.

The denial itself is only half the story, and it's the less important half. A large share of denied claims never get resubmitted, which means the metric practices should actually worry about isn't denial rate. It's recovery rate. Most small practices have no formal process for either one. Reworking a single denied claim costs meaningful staff time and resources, and for a lot of low- and mid-dollar claims, that cost exceeds the expected reimbursement. So practices make a quiet, rational decision to abandon claims that were actually valid. That's where revenue disappears: not in some dramatic denial spike, but in the slow accumulation of claims nobody had time to fight. Layer onto that the ordinary leakage from undercoding and inefficient charge capture, which industry observers commonly cite as a meaningful share of revenue, meaning a practice billing several million dollars a year may be leaving a significant sum on the table before a single denial even enters the picture.

Here's the detail that should change how practices think about this entirely. KFF reported that Medicare Advantage insurers made 52.8 million prior authorization determinations in 2024 and denied 7.7% of them. But when practices actually filed appeals, 80.7% of those denials got overturned. That overturn rate isn't a footnote, it's the whole story: the majority of MA denials were beatable from the start, and the only reason they became lost revenue is that nobody appealed them. Billing inefficiency isn't a background cost for a small practice. It's often the line between staying open and not, and most of what's being lost was never actually owed to the payer in the first place.

The benchmarks a small practice needs before talking to any vendor

Before any vendor conversation happens, a practice needs its own numbers on the table. A vendor who opens with outcome promises before asking what the baseline looks like is selling, not diagnosing, and that ordering problem alone should end the conversation.

Five metrics matter here. Clean claim rate should sit at 94% or above; below that, claims are bouncing before a human even gets a look at them. Denial rate averages 12 to 15% industry-wide, but the real target is under 5%, with top performers running under 3%. Days in AR under 30 is strong, 31 to 40 is tolerable, and anything past 50 signals a structural cash flow problem, not a temporary one. Net collection rate above 96% is good, 90 to 95% is typical, and anything under 90% points to systemic revenue loss rather than a one-off. AR aging matters too: the 0-to-30-day bucket should make up the majority of total AR, and claims older than 30 days exceeding 30% of total AR, since aged claims lose collectability the longer they sit.

These numbers move together, and fixing the wrong one first wastes months. Improve clean claim rate and rework cycles drop, so cash arrives faster on the days-in-AR side almost automatically. That's why fixing submission quality up front is the single highest-leverage move a practice can make, well ahead of chasing better appeals after the fact.

Days in AR also has a consequence beyond cash flow that a lot of small practice owners miss entirely: it distorts practice valuation. A high days-in-AR number inflates the AR line on the balance sheet while actual cash lags behind it, opening a gap between what the books say and what the bank account shows. For a practice weighing a sale, a merger, or financing, that gap is not academic. So when a vendor says "we improve collections" or "we reduce denials," the follow-up question is simple: improved against what baseline, which of these five metrics do they report on, and how often?

How payer behavior shapes what "good billing" requires in practice

Denials aren't random noise. The most common reasons, incomplete documentation, lack of medical necessity, missing prior authorization, coding discrepancies, follow patterns specific to each payer. A billing operation that treats every payer the same is already behind, and here's the part vendors don't like to say out loud: payers are running their own AI to catch claims before they pay, screening for anything that doesn't meet their internal definition of medical necessity. If a practice's billing system doesn't carry payer-specific intelligence, it's operating a step behind the payer's detection system, not on equal footing with it.

Medicare Advantage plans show some of the most aggressive denial behavior in the market, with rejection rates between 6.1% and 9%, and some facilities reporting even higher. Combined with the 80.7% appeal overturn rate cited above, the pattern is hard to miss: a large share of these denials are procedurally generated, not clinically justified. Payer policy also shifts without warning, and a rule change can trigger a denial spike that a small practice doesn't notice until month-end close, by which point the window to fix it has mostly closed.

So the question worth asking a vendor isn't whether the system scrubs claims. Any system scrubs claims. It's whether the system knows how a specific payer has behaved on a specific claim type over the last 90 days, because that distinction is what separates a reactive tool from something that actually thinks ahead. For practices concentrated in one or two payers, often the case in Medicare Advantage-heavy markets, a vendor's depth of knowledge on that single payer matters more than breadth across a hundred payers the practice barely touches.

Why AI alone is not enough: the human-oversight requirement

A lot of what gets marketed as "AI-powered" billing is older rules-based automation with a new label stapled on. The real test is whether the system learns from a specific practice's payer mix, specialty, and denial history, or runs the same generic ruleset for every customer regardless of who they are.

One diagnostic works better than any sales deck: pull a denied claim from last quarter and ask the vendor to walk through exactly how their AI would have caught it before submission. A vendor doing real work walks the reasoning step by step. A vendor running rebranded automation changes the subject, every time, and that's worth watching for directly in the room.

AI is genuinely good at pattern recognition and speed across volume, and it's good at surfacing exceptions a person would take hours to find manually. But the exceptions still need a human who understands how a particular payer actually behaves, what appeal language has worked before, and which fixes stick over time rather than just resolving the one claim in front of them. That institutional knowledge, a payer's quirks, a specialty's documentation demands, a particular adjudicator's tendencies, compounds in value the longer it's retained. Most small practices lose it the moment a billing staffer leaves, because nobody wrote it down anywhere. A service that pairs AI detection with in-house billing specialists keeps that memory intact on purpose, rather than hoping it survives staff turnover.

Among organizations already using AI in billing, 69% report the technology has boosted claims success by cutting denials or improving resubmission rates. That statistic needs a caveat attached to it: it describes organizations already using AI well, not the average adopter dropping software into an unstaffed billing function. The outcome depends almost entirely on whether a human is actually working what the AI flags. A system that surfaces exceptions but leaves an already understaffed practice team to resolve them hasn't removed the bottleneck. It's just relocated it, usually to the same overworked staffer who couldn't keep up before.

Integration and operational fit: what "works with your EHR" actually means

The fear driving a lot of small-practice hesitation is simple: will this force a switch to a new EHR, or require retraining the front desk before any revenue benefit shows up? Any vendor requiring either one is adding implementation risk before the practice has seen a dollar of return, and that risk should weigh heavily against whatever the sales deck promises.

Integration depth varies more than the marketing suggests, and the phrase "integrates with all major EHRs" rarely tells you which version you're getting. Some platforms run true bidirectional data exchange with a practice's existing EHR and clearinghouse. Others amount to a flat-file export that someone still has to touch manually.

A few questions expose the real answer fast. Is eligibility verification triggered automatically at scheduling, or does a staffer have to kick it off manually? Does the system post payments back to the EHR in real time, or batch them overnight? When a denied claim gets reworked, does the correction flow back through the same clearinghouse connection, or does someone resubmit it by hand? And when a payer changes policy, does the vendor push that update automatically, or is the practice left to configure it themselves?

Timeline matters too. A 40-day implementation and a multi-quarter rollout are not the same commitment for a practice bleeding revenue every month it waits. Ask for reference practices of similar size and specialty who can speak to actual go-live dates, not projected ones. HIPAA compliance and data security, meanwhile, aren't features to be impressed by. They're the floor. Any vendor pitching security as a premium add-on, or one that can't clearly describe its own compliance posture, isn't a credible partner for handling protected health information. The deeper question underneath all of this: does the service reduce the practice's administrative burden, or just swap one set of manual tasks for another that now involves babysitting a vendor relationship?

Which vendors offer AI medical billing services suited to small practices with flexible pricing?

The market splits into two segments, and a practice needs to know which one it's shopping in before it looks at individual vendors. Autonomous coding and large-system RCM platforms, the kind built by companies like CodaMetrix and AKASA, are designed for hospitals and large health systems, priced on custom, volume-based contracts that assume enterprise scale. They are not built around small-practice workflows or small-practice budgets, and a small practice evaluating them is wasting a sales cycle. The segment that actually matters here is all-in-one platforms and managed billing services aimed at small to mid-size practices.

Within that segment, the options differ from each other in ways worth naming specifically. PracticeSuite (G2 rating 4.3/5, Capterra 4.0/5) is an all-in-one billing and practice management platform with denial intelligence built into pre-submission review, rules-based auto-posting, and workflow customization by role. It's been operating for over two decades, though a very small practice may find it has more features than it needs, and getting the most out of its automation requires upfront rule customization.

CureMD offers predictive analytics and AI-driven coding and claims automation, claiming a first-pay rate above 95% and a 40% cut in days in AR. It doesn't publicly disclose how many EHR systems it integrates with or which ones, and there's no publicly disclosed long-term compliance track record, worth weighing for a risk-averse practice. DrChrono combines EHR and billing in one mobile-friendly platform, running $199 to $499 per provider monthly plus additional billing fees and setup costs, though it suits practices wanting a combined EHR and billing solution with strong mobile access rather than a dedicated AI-first billing platform. NextGen Healthcare runs a more traditional billing platform with EHR integration, built for ambulatory practices of every size but with particular strength for mid-size to large specialty groups; pricing is not publicly listed, and the feature set often exceeds what a small practice actually needs. CharmHealth takes a modular, cloud-based approach aimed at small to midsize practices, with an AI-powered EHR and customizable practice management, starting free and charging for specific added features, which lets practices adopt incrementally rather than committing all at once. DoctorConnect RCM integrates with more than 150 EHR and practice management systems and covers eligibility verification, copay estimation, patient engagement, and RCM in one platform, with zero HIPAA violations reported over more than 30 years in operation; pricing isn't public and requires direct inquiry, and the feature set may be more than a very small or non-integrated practice needs.

There's a separate category worth naming on its own, and it's the one small practices should look at hardest: managed billing services that combine AI claim scrubbing and denial management with in-house billing specialists, rather than selling software a practice's own team has to operate. Software tool versus full-service billing operation is the foundational choice a practice needs to make before it even starts comparing vendors, and a practice without the staff to run a billing department shouldn't be shopping for software in the first place. Pricing across this market ranges from flat per-provider fees to a percentage of collections, with reputable billing companies typically charging mid-single digits to 10% of monthly collections. A percentage model ties the vendor's incentives to the practice's actual revenue performance; a flat fee is predictable but doesn't scale with results either direction. Altair Health falls into this full-service category, combining automated claim operations with in-house billing specialists who work the exceptions the AI surfaces, so denial recovery becomes an active strategy tailored to each payer's specific behavior rather than a batch process running on generic appeal templates. For a small practice that can't staff, manage, and retain a billing department internally, that combination addresses the actual gap rather than papering over it with more software.

The evaluation questions that separate credible vendors from marketing claims

Everything above points toward a short list of questions worth asking directly, in the room, before signing anything.

On AI capability: does the system train on the vendor's entire customer base, or specifically on this practice's payer mix and denial history? Can the vendor pull up a real denied claim and explain exactly how their model would have caught it beforehand, not in general terms but for that specific claim? What's the false-positive rate on flagged claims, and how much manual review does that actually require downstream?

On human oversight: are there in-house billers working denial recovery systematically, where AI surfaces the exception but a person decides the recovery strategy for that payer's particular pattern? Or does the exception land back in the practice's inbox to be worked by staff who don't have time for it? Ask directly whether the human layer is included in the service or billed as an add-on, because that answer determines whether the bottleneck actually moves or just changes location.

On payer intelligence: can the vendor speak to how a specific payer, the one the practice deals with most, has behaved on a specific claim type in the last quarter? Generic claims-scrubbing language without payer specificity is a sign the system hasn't been built for the kind of concentrated payer exposure a lot of small practices actually carry.

On integration: is data exchange with the practice's EHR bidirectional, or does someone still move files by hand? What does a 90-day implementation actually look like, and can the vendor produce a reference practice of comparable size who lived through it?

And on the numbers, always back to the numbers: which of the five core metrics, clean claim rate, denial rate, days in AR, net collection rate, AR aging, does the vendor report on, and how often? A vendor unwilling to commit to specific, measurable answers on any of these isn't offering a partnership. It's offering a pitch.